The appearance of fibrin provides the end-point in every clotting test, and the duration of the thrombin-fibrinogen reaction is thus a component of any measurement of clottinig time' While many tests are designed to study the early stages of clotting, in interpreting the results it is necessary to consider to what extent the observed differences may be due simply to differences in the " indicator reaction" between thrombin and fibrinogen. This precaution particularly applies to one-stage tests in which comparisons are made between different bloods.
The reaction between thrombin and fibrinogen may be separately investigated, and fortunately the measurement of the thrombin clotting time of citrated plasma (Biggs and Macfarlane, 1953 ) is one of the simplest of all clotting tests. This paper reports a case in which the one-stage prothrombin time was spuriously lengthened by an abnormally slow thrombin-fibrinogen reaction; tests were then made in four other cases to investigate the processe3 involved. Case Presentation E. M., a man aged 29, had a malabsorption syndrome with ascites and tetany. The whole blood calcium was 5 mg.%, plasma albumin 1.25 g.%, plasma globulin 1.72 g.%, blood urea nitrogen 20 mg.%, blood fatty acids 405 mg.%, packed cell volume 34%, and cephalin flocculation + ++.
The one-stage prothrombin time with human brain reagent was prolonged. The thrombin clotting time was observed over a period of a year and was always greatly prolonged. These results are shown in Table I, with two readings of the plasma fibrinogen concentration. The first of these was made by the microKjeldahl nitrogen method and the second by a clot-weight method (Ingram, 1952a) : both are within normal limits (Ingram, 1952b (Table II) . Isolation of Fibrinogen.-Equal volumes of control and patient's plasma were precipitated at *-saturation with ammonium sulphate and the precipitates were taken up in 0.85% saline; the precipitation was once repeated and the solutions were dialysed for 20 hours against saline. It was noted that the patient's precipitates spun down more readily than those from the control plasma. Samples of these solutions were diluted 50:50 with veronal buffer pH 6.8 (Owren, t The ratios suggest that the magnitude of the effect is independent of the clotting time.
(1) Equal volumes of patient's and control plasma were precipitated at i-saturation with ammonium sulphate. The precipitates were drained, dissolved in saline containing one-tenth volume of veronal buffer pH 6.8, and made up to the volumes of the original plasmas. The procedure was once repeated and the solutions dialysed overnight against the same solvent.
Plasma obtained from two other persons was pooled and defibrinated with a trace of thrombin.
Thrombin clotting times were then measured on each fibrinogen, both with and without the addition of defibrinated plasma, to confirm that the relative reactivity of the samples had not been greatly altered by the isolation (Table IV) .
One-stage prothrombin times with human brain extract in four dilutions were then measured on each fibrinogen in clotting mixtures containing 0.1 ml. each Table V , which shows that the proportional difference between the clotting times from the two fibrinogens increased as the clotting times lengthened. Now, Table IV showed that the proportional differences between the thrombin clotting times of these fibrinogens did not increase as the clotting time lengthened, so Table V suggests that, as the prothrombin time lengthens, the time required for the interaction between thrombin and fibrinogen represents an increasing fraction of the interval elapsing between recalcification and the appearance of clot. A hypothetical example will make this clear. Suppose, for instance, that the thrombin-fibrinogen reaction occupies one-tenth of the whole prothrombin time when this is 20 sec., and two-tenths when, by dilution of the brain reagent, the prothrombin time is increased to 50 sec. ; then, in the one case the thrombinfibrinogen reaction will constitute the final two seconds and in the other, the final 10 seconds. Suppose, further, that in two plasmas the thrombinfibrinogen reactions proceed at differing rates in the ratio 7: 10. Other things being equal, the prothrombin times of these plasmas will follow the values given in Table VI . The differences shown in the tests will be relatively smaller with concentrated brain and relatively greater with dilute brain. If it is alternatively assumed that the thrombin-fibrinogen reaction occupies a constant fraction of the prothrombin time, this effect does not appear.
(2) Two weeks later further samples of citrated blood were obtained from this patient and from a different control subject. Fibrinogen was isolated by the method of Jaques (1943) , employing phosphate buffers at pH 6.6, and dialysed against saline overnight. The results were similar to those in the previous experiment: the mean thrombin clotting times of the patient and control fibrinogen solutions alone (each derived from four readings) were 7.9 sec. and 10.0 sec. respectively (ratio, 0.79); and the mean prothrombin times with diluted brain extract on defibrinated plasma were 36.6 sec. and 42.1 sec. respectively (each derived from four readings: ratio, 0.86). These and the previous findings were broadly in agreement.
In conclusion, the effect on the one-stage prothrombin time suggested that, as the clotting time was lengthened by dilution of the brain reagent, the thrombin-fibrinogen reaction came to occupy an increasing fraction of the interval recorded as the prothrombin time. the patient's and control plasmas as before. Table  VII gives the thrombin clotting times on the fibrinogen solutions alone and the prothrombin times with defibrinated plasma from another source, as in the previous experiments. The results are similar to those from the previous case.
These samples were then used to test the hypothesis that the "fast" fibrinogen sample contained an accelerator of thrombin generation, whose activity might explain the difference in the prothrombin times when the fibrinogens were tested with defibrinated plasma. Two-stage prothrombin time curves were obtained at 23°C. from mixtures containing 67°% defibrinated plasma, 28% fibrinogen solution, and 1.7°o molar calcium chloride solution. Duplicate curves were obtained from each fibrinogen with brain extract in final concentrations of 2.8% and of 0.28%. The mixtures clotted on the rising limbs of the curves at about 1 min. with the concentrated brain extract and at about 1.5 min. with the dilute extract. With each concentration of brain extract, the rising limbs of the four curves could be closely superimposed.
In conclusion, there was no evidence that the fibrinogen isolate contained an abnormal accelerator of thrombin generation.
Effect of Fibrinogen Concentration upon Differences in Thrombin Clotting Time.-Citrated plasma was obtained from a patient in whom the fibrinogen concentration was raised and the thrombin-fibrinogen reaction was delayed, relative to normal blood.
The fibrinogen concentrations were determined in the patient's (0.51 g.% ) and the control (0.29 g. I/ ) plasmas and a portion of the patient's plasma was diluted with saline to reduce the fibrinogen concentration to that of the control. Fibrinogen solutions were prepared from equal volumes of each sample by Jaques's method, as before. The fibrinogen concentration was determined on the three samples (patient, control, and diluted patient) and serial dilutions in saline were prepared from them. Two to four replicate readings of the thrombin clotting time The graph shows three things. First, the relationship between fibrinogen concentration and thrombin clotting time (found by some observers and reviewed by Owren, 1947; confirmed by Shinowara, 1948 ) is clearly shown, with the optimum concentration being approached at about the normal plasma level. Second, the relative reactivity of the patient's and the control fibrinogen is independent of the concentration tested. Third, this relationship is also independent of the concentration of fibrinogen in the plasma samples from which the isolates were prepared.
In conclusion, the fibrinogen of this patient's plasma appeared to react with thrombin abnormally slowly. In a purified system, the effect was independent of the fibrinogen concentration and it was not a function of the difference between the concentrations of fibrinogen in the original plasmas.
Effect of Other Plasma Constituents upon Differences in Thrombin Clotting Time.-The thrombin clotting time was found to be more rapid in citrated plasma from another patient than in citrated plasma from either of two controls (patient, 9.0 sec. ; control A, 9.7 sec.; control B, 10.8 sec.; each derived from four readings).
To determine whether the effect was related to differences between the fibrinogens or between other plasma constituents, equal samples of plasma from the patient and from control A (from whom the patient differed the less) were treated as follows:
One pair of samples was defibrinated with a trace of thrombin, and from another pair the fibrinogens were precipitated by i-saturation with ammonium sulphate ; these precipitates were drained with filter papers and taken up in distilled water to twice the volumes of the original plasma but were not dialysed. Equal mixtures of each plasma with each fibrinogen were prepared and thrombin clotting times obtained (Table VIII) . In the results differences between the fibrinogens are apparent, but not between the plasmas. The differences between the results from the two plasmas are not significant; but between the fibrinogens, P<0.01.
In conclusion, the rapid thrombin clotting time of this patient's plasma was a property of the fibrinogen and not of other plasma constituents.
Discussion
When blood clots spontaneously there is a latent period of some minutes before thrombin appears in the system, but thereafter the concentration rises sharply to about 10 units/ml.; the liberation of thrombin with brain extract follows a similar course, but the latent interval is much reduced (Macfarlane and Biggs, 1953) . It is commonly observed in two-stage tests (as in the experiment reported above) that clotting occurs at a fairly low thrombin concentration but while the concentration of thrombin is still rising rapidly, so that under physiological conditions the rate of the thrombinfibrinogen reaction may be partly determined by the rate of liberation of thrombin.
The rate of thrombin liberation was found to be reduced by dilution of the brain extract in twostage tests on defibrinated plasma (Ingram, 1955) . This reduction was comparable to the low rate of liberation of thrombin observed in thrombocytopenic and haemophilic blood (Macfarlane and Biggs, 1953) . The supposition of a prolonged thrombin clotting time under such conditions agrees well with the results of the prothrombin time experiment in the second case studied.
In the thrombin clotting time test the concentration of thrombin is brought almost instantaneously to the test level, so that the conditions do not closely simulate the physiological clotting of fibrinogen. A rising concentration of thrombin would be difficult to reproduce in a simple test, but the ordinary method of measuring thrombin clotting time seems, from the above observations, to reflect at least some features of the normal process.
The biochemistry of the reaction between thrombin and fibrinogen has been extensively studied (Laki, 1953 ; Lorand, 1954; Bailey and Bettelheim, 1955) , and the experimental error of the measurement of thrombin clotting time is among the lowest of " one-stage " clotting tests (Ingram and Armitage, 1952 ; further details of experimental error are given in the Appendix). The reaction is believed to occupy the final two to five seconds in the clotting of normal blood in a glass tube (Biggs, 1955) . Proceeding at this rapidity the reaction is unlikely to be affected by variations in "progressive antithrombin," and this has been confirmed by Lyttleton (1949) .
Clinical Use of the Test.-It is convenient to mix 0.1 ml. of citrated plasma and 0.1 ml. of saline and then to time the reaction after adding 0.1 ml. of thrombin solution diluted so that the resulting clotting time is about 10-20 sec. These quantities are economical in reagents and provide the same concentration of plasma as in the one-stage prothrombin time test.
The reaction between thrombin and fibrinogen is affected in various ways by ionized calcium (Robbins, 1944; Laki and Loraind, 1948; Burstein, 1951 ; Ferry, Miller, and Shulman, 1951 ; Rosenfeld and Jainszky, 1952; Burstein and Guinand, 1954) , so that for clinical investigation the reaction should be measured in recalcified plasma; this is conveniently done either by replacing the saline with M/40 calcium chloride solution or by adding to the diluted thrombin one-fortieth of its volume of molar calcium chloride solution.
Thrombin may be prepared by the method of Douglas and Biggs (1953) . Prepared thrombin is available from various sources (e.g., the bovine thrombin, " topical," of Parke, Davis & Co.) . In a comparative study of the thrombin clotting times with human and bovine thrombins, five out of six human plasmas reacted somewhat differently to the two thrombins, and it is therefore thought that human thrombin should be used for clinical investigations.
The thrombin clotting time might advantageously be measured more often in clinical work than current publications suggest to be the case. The test is affected by heparin, but may be returned to normal by adding toluidine blue (Biggs and Macfarlane, 1953) . This therefore provides a simple indication of heparinaemia. The test becomes progressively more sensitive to heparin as the thrombin concentration is reduced (Biggs, 1955) . It is also possible that clinical abnormalities of blood coagulation may be associated with disturbances of the thrombin-fibrinogen reaction, but little evidence has yet been presented. Summary A case is described in which a lengthening of the prothrombin time seemed to be due to an abnormally slow reaction between thrombin and fibrinogen.
Investigations in other patients suggested that, as the prothrombin time lengthened, the thrombinfibrinogen reaction occupied an increasing fraction of the interval between recalcification and the appearance of the clot; and that differences observed between the thrombin clotting times in normal and abnormal plasmas depended upon a property of the fibrinogens and were independent of fibrinogen concentration, thrombin concentration, or other plasma constituents. (Table X) of the mean of all the readings. The significance of the difference between the means was tested by regarding the ratio of the difference to its standard error as a normal deviate: if the ratio exceeded 1.96, the probability of a greater difference arising by Where n, and n2 are the numbers of replicates making up the two series of readings (ordinarily, of course, n5 = n2), y is the grand mean and S.E. is the required standard error of the difference between the means of the two series.
chance was less than 1 in 20 (P<0.05); if the ratio exceeded 2.58, the probability was less than 1 in 100 (P<0.01).
A significant difference does not necessarily imply a pathological difference, for significant differences are to be expected within the normal range. The value of the significance test is that it shows when apparent differences may be discounted on the grounds of experimental error alone.
Coefficients of variation which have been obtained from replicate readings of one-stage prothrombin times made by the same observer (for the experiment shown in Table V Further details of the investigation into the variability of the test results will be published elsewhere. 
